Articles

Source Code Capital portfolio company METiS Pharmaceuticals announced the completion of angel+ and Pre-A funding rounds totaling over 100 million yuan, with existing investor Source Code Capital continuing to increase its stake.

Source Code Capital portfolio company METiS Pharmaceuticals announced the completion of angel+ and Pre-A funding rounds totaling over 100 million yuan, with existing investor Source Code Capital continuing to increase its stake.

It was the first to propose building an AI-driven formulation development platform, jointly advancing new formulation drugs to clinical trials.

Source Code Capital portfolio company WANGBAOBAO announced the completion of a Series C financing round worth several hundred million yuan, with existing shareholder Source Code Capital continuing to increase its stake.

Source Code Capital portfolio company WANGBAOBAO announced the completion of a Series C financing round worth several hundred million yuan, with existing shareholder Source Code Capital continuing to increase its stake.

Leveraging brand momentum to continuously break into new circles, it has already covered over 10,000 offline retail terminals, with offline sales accounting for 40% of total volume in a single month.

Visual inspection technology company Dinnar announced the completion of a Series B financing round worth hundreds of millions of RMB, led by Source Code Capital.

Visual inspection technology company Dinnar announced the completion of a Series B financing round worth hundreds of millions of RMB, led by Source Code Capital.

Dedicated to providing machine vision inspection solutions, with coverage across 3C, automotive, 5G, display panel, semiconductor, and other vertical scenarios.